Design, Synthesis, And In Vitro Cytotoxic Investigations Of Several New Arylidene-hydrazinyl-thiazoles As Anticancer And Apoptosis-inducing Substances

Abstract

One Of The Biggest Challenges Facing Modern Healthcare Is Cancer, A Complex And Pervasive Group Of Diseases Characterised By Unchecked Cell Proliferation And The Potential For Metastasis. Cancer Is The Second Most Common Cause Of Death Worldwide, With A Wide Range Of Malignancies Displaying Distinct Biological Characteristics And A Significant Impact On People, Families, And Societies.1, 2 Even Though Traditional Therapies Like Radiation, Chemotherapy, And Surgery Have Frequently Increased Survival And Brought About Remission, Their Effectiveness Is Frequently Undermined By Serious Side Effects, Requiring A Careful Balancing Act Between The Advantages Of Treatment And The Welfare Of The Patient. With The Advent Of Precision Medicine, Immunotherapies, And Targeted Medicines, The Field Of Cancer Treatment Has Changed Dramatically In Recent Years.

Keywords